Live on May 21st-In a game that ended in the current Premier League, Liverpool drew 1-1 with Aston Villa, and firmino scored an equalizer.
This game is Liverpool’s last home game of the season. After the game, the whole Liverpool team lined up to say goodbye to firmino, who was about to leave the team, and the fans applauded constantly.
Last night and this morning, the Premier League was the firstTwosevenRound of fierce battles,Manchester city away1-0Beat Crystal Palace and fall behind Arsenal.TwoPoints, Harland scored the only goal;Chelsea awaythree-1Beat leicester city and win various events.3 consecutive victories; Tottenham home 3-1Beat Nottingham Forest and stay first in the league.4, Kane scored twice and Sun Xingyu broke the door; Liverpool away game0-1Lost to Bournemouth, opened the gap by Tottenham.
Chelsea awaythree-1Beat leicester city and win various events.Three consecutive victories. First place in the first halfoneMinutes later, coulibaly made a cross and Chilwell scored a low shot. sequencethreenineMinutes, Dhaka shot outside the restricted area to break the goal to equalize the score; At halftime, Enzo picked the ball and Havertz scored an offside shot to help Chelsea take the lead again. sequenceseveneightMinutes later, Moudrek headed the ferry, and Kovacic volleyed to seal the victory; sequenceeightsevenMinutes later, the home team, Fass, got the first place.Two yellow cards were sent off, and leicester city was powerless.
Hotspur home courtthree-1Beat Nottingham Forest and stay first in the league.Four people. sequenceNineteenMinutes later, Poirot made a cross from the right and Kane headed the goal. sequencethreefourMinutes later, Richarlyson made a penalty, and Kane scored twice. sequencesixTwoMinutes later, Richarlyson made a cross from the right, and Sun Xingyu scored a low goal after stopping the ball, which sealed the victory. sequenceeightoneMinutes later, the visiting team took a corner kick, and voller headed the goal and pulled back a point; Then neither side made any achievements, and Tottenham won at home.3 points, stop the decline.
In other competitions,Manchester city away1-0Beat Crystal Palace and fall behind Arsenal in the first round.TwoPoints, Harland some goals;Liverpool away gameZero-1Billing scored the only goal after losing to Bournemouth, and Bournemouth left the relegation zone after winning; Everton home courtone-0Beat brentford and end your opponent.oneTwoUnbeatable; Leeds United home courtTwo-2In the draw with Brighton, Japanese star Miyuki sent an assist.
When Microsoft and Google try their best for whose artificial intelligence chat robot is better, we can easily find that this is not the only purpose of machine learning and language model. In addition to the rumored plan to showcase more than 20 products driven by artificial intelligence in this year’s annual Google I/O event, Google is moving towards the goal of establishing an artificial intelligence language model that supports 1000 different languages.
In the update released on Monday, Google shared more information about the Universal Speech Model (USM), which Google called a "critical first step" to achieve its goal.
YouTube has used USM to generate closed captions, and it also supports Automatic Speech Recognition (ASR), which can automatically detect and translate languages, including English, Mandarin Chinese, Amharic, Cebu, Assam and so on.
Now, Google USM supports more than 100 languages, and will be used as a "foundation" to build a wider system. At the same time, Meta is developing a similar artificial intelligence translation tool, but it is still in its early stage.
You can read more about USM and how it works in research papers published by Google:
One goal of this technology may be to detect and provide real-time translation in augmented reality glasses, just like the concept demonstrated by Google in I/O activities last year. However, this technology seems to be a little far away, and Google’s wrong expression of Arabic during the I/O conference proves how easy it is to make mistakes.
Monoclonal antibody against B-cell psoriasis leukemia, a target of cancer artificial intelligence
①Nature：Cancer will cost the world $25 trillion over next 30 years
In the next 30 years, cancer may cost the world $25 trillion.
DOI :10.1038/d41586-023-00634-9
②Seminars in Cancer Biology：Artificial intelligence in cancer immunotherapy: applications in neoantigen recognition, antibody design and immunotherapy response prediction
Review: Application and development of artificial intelligence in the field of precision oncology: new antigen recognition, antibody design and immunotherapy response prediction.
DOI :10.1016/j.semcancer.2023.02.007
③Molecular Cancer：CD39/CD73/A2AR pathway and cancer immunotherapy
Review: New progress in pathophysiological function of CD39/CD73/A2AR pathway in cancer development, metastasis and drug resistance.
DOI :10.1186/s12943-023-01733-x
④Immunity：B cell receptor signaling in germinal centers prolongs survival and primes B cells for selection
B cell receptor signal transduction in germinal center prolongs the survival of B cells and initiates the selection of B cells.
DOI :10.1016/j.immuni.2023.02.003
⑤Frontiers in Immunology：Metabolic rewiring in keratinocytes by miR-31-5p identifies therapeutic intervention for psoriasis
The metabolic recombination of miR-31-5p in keratinocytes determines the intervention on psoriasis.
DOI :10.15252/emmm.202215674
⑥Journal of Hematology & Oncology：Novel agents and regimens in acute myeloid leukemia: latest updates from 2022 ASH Annual Meeting
The latest drug research and new scheme progress of American Society of Hematology (ASH) for acute myeloid leukemia (AML)
DOI :10.1186/s13045-023-01411-x
⑦FDA extended the review of adult Roctavian with severe hemophilia A because of "significant changes in a large number of additional data"
⑧ A small molecule MET inhibitor, gumetinib, which was developed by Shanghai Institute of Pharmacology, China Academy of Sciences, was approved for marketing, and it was used for locally advanced or metastatic non-small cell lung cancer (NSCLC) with the jump mutation (METex14 jump) in exon 14 of mesenchymal-epithelial transforming factor (MET).
⑨ The clinical study of Relma-cel targeting CD19 for first-line high-risk large B-cell lymphoma was officially launched.
⑩ Lilly will terminate the research and development of Solanezumab for Alzheimer’s disease because it fails to slow down the cognitive decline of preclinical Alzheimer’s patients.
The world of scientific exploration is full of challenges. AtaGenix pays tribute to every pioneer and is more committed to becoming your trusted partner!